Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Qiagen ( (QGEN) ) is now available.
QIAGEN N.V. announced a synthetic share repurchase resulting in the consolidation of shares, where every 36 shares were consolidated into 35 shares. This transaction, which affects stakeholders including board member Metin Colpan, was part of a broader strategy approved in 2024 to streamline the company’s share structure.
More about Qiagen
QIAGEN N.V. operates within the life sciences industry, primarily focusing on providing sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical applications. The company is known for its innovative solutions that enable customers to gain valuable insights from biological samples.
YTD Price Performance: -0.02%
Average Trading Volume: 949,621
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $9.69B
For an in-depth examination of QGEN stock, go to TipRanks’ Stock Analysis page.
